Dual Antiplatelet Therapy after PCI: When Could We Go Shorter?
The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains an important clinical question in interventional cardiology. Several clinical and angiographic variables are associated with an increased risk for thrombotic events, and prolonged DAPT dur...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/75608 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Dual Antiplatelet Therapy after PCI: When Could We Go Shorter?
- Dual Antiplatelet Therapy
- Antiplatelet therapy in cardiovascular disease /
- Effect of Antiplatelet Therapy on Suboptimal Reperfusion
- Antiplatelet Therapy in Cardiovascular Disease – Past, Present and Future
- Concept-Based Explanations in Computer Vision: Where Are We and Where Could We Go?
- A Year after - Could We Move beyond Psychosomatics and Dissociation